Max Isberg

Max Isberg is a Senior Analyst at Avoro Capital Advisors in New York, specializing in quantitative analysis and portfolio analytics within the biotechnology and pharmaceutical sectors. In this capacity, he supports investment decisions by leveraging statistical modeling, data-driven insights, and sector expertise focused on life sciences equities.

Before joining Avoro Capital in 2019, Max was an Analyst and trader at Apex Capital Holdings, where he managed a long/short equity portfolio with a particular emphasis on biotechnology and pharmaceutical names. His progression at Avoro from Analyst to Senior Analyst reflects a deepening responsibility in portfolio construction and investment research tied to healthcare assets.

Max graduated summa cum laude from Tufts University with a B.S., majoring in mathematics and economics. His blend of rigorous quantitative training and sector-specific experience positions him as a specialist in healthcare public equities, notably biotechnology and specialty therapeutics.